drugset / Trial / NCT06881550

Real-world Study on Shenbailing Granules for Improving Qi and Blood Deficiency in Patients After Breast Cancer Surgery

NCT06881550 ↗

Enrolling by invitation 2000 enrolled Caigang Liu
Non-randomizedParallel-groupOpen-labelTreatment

Summary

This study aims to explore the clinical efficacy of Shenbailing granules in improving quality of life and reducing cancer-related fatigue in a real-world setting, with the goal of providing clinical evidence for the use of Shenbailing granules in alleviating cancer-related fatigue among post-breast cancer surgery patients.

Timeline

Start
2024-12-30
Primary completion
2025-12-10
Completion
2026-12-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Shenbailing Unknown — —

Indications